Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A randomized trial of immunotherapy for persistent genital warts.

Jardine D, Lu J, Pang J, Palmer C, Tu Q, Chuah J, Frazer IH.

Hum Vaccin Immunother. 2012 May;8(5):623-9. doi: 10.4161/hv.19319. Epub 2012 May 1.

2.

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.

Vandepapeliere P, Barrasso R, Meijer CJ, Walboomers JM, Wettendorff M, Stanberry LR, Lacey CJ.

J Infect Dis. 2005 Dec 15;192(12):2099-107. Epub 2005 Nov 11.

3.

Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.

Han JE, Wui SR, Park SA, Lee NG, Kim KS, Cho YJ, Kim HJ, Kim HJ.

Vaccine. 2012 Jun 13;30(28):4127-34. doi: 10.1016/j.vaccine.2012.04.079. Epub 2012 May 1.

PMID:
22561312
4.

Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.

Fraillery D, Zosso N, Nardelli-Haefliger D.

Vaccine. 2009 Apr 14;27(17):2326-34. doi: 10.1016/j.vaccine.2009.02.029. Epub 2009 Feb 20.

PMID:
19428847
5.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E.

Lancet Oncol. 2005 May;6(5):271-8.

PMID:
15863374
6.

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA.

Arch Dermatol. 1998 Jan;134(1):25-30.

PMID:
9449906
7.

Activity of HspE7, a novel immunotherapy, in patients with anogenital warts.

Goldstone SE, Palefsky JM, Winnett MT, Neefe JR.

Dis Colon Rectum. 2002 Apr;45(4):502-7.

PMID:
12006932
8.

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.

Rowhani-Rahbar A, Mao C, Hughes JP, Alvarez FB, Bryan JT, Hawes SE, Weiss NS, Koutsky LA.

Vaccine. 2009 Sep 18;27(41):5612-9. doi: 10.1016/j.vaccine.2009.07.027. Epub 2009 Jul 30.

9.

Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles.

García-Piñeres A, Hildesheim A, Dodd L, Kemp TJ, Williams M, Harro C, Lowy DR, Schiller JT, Pinto LA.

Clin Vaccine Immunol. 2007 Aug;14(8):984-9. Epub 2007 Jun 27.

10.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.

López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, Arteaga-Ruiz O, Arriaga-Pizano L, Hickman SP, Allende M, Lenhard K, Pincus S, Connolly K, Raghunandan R, Smith G, Glenn G.

Vaccine. 2011 Oct 13;29(44):7826-34. doi: 10.1016/j.vaccine.2011.07.099. Epub 2011 Aug 2.

PMID:
21816199
11.

Treatment of genital warts with an immune-response modifier (imiquimod).

Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr.

J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):230-9.

PMID:
9486679
12.
13.

Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.

García-Piñeres AJ, Hildesheim A, Dodd L, Kemp TJ, Yang J, Fullmer B, Harro C, Lowy DR, Lempicki RA, Pinto LA.

J Immunol. 2009 Feb 1;182(3):1706-29.

14.
15.
16.

Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study.

Gupta S, Malhotra AK, Verma KK, Sharma VK.

J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1089-93. doi: 10.1111/j.1468-3083.2008.02719.x. Epub 2008 May 15.

PMID:
18484970
17.

Interferon therapy for condylomata acuminata.

Eron LJ, Judson F, Tucker S, Prawer S, Mills J, Murphy K, Hickey M, Rogers M, Flannigan S, Hien N, et al.

N Engl J Med. 1986 Oct 23;315(17):1059-64.

PMID:
3531860
18.

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

Stanley M, Lowy DR, Frazer I.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. Epub 2006 Jun 23. Review.

PMID:
16949996
19.
20.

Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.

Stockfleth E, Beti H, Orasan R, Grigorian F, Mescheder A, Tawfik H, Thielert C.

Br J Dermatol. 2008 Jun;158(6):1329-38. doi: 10.1111/j.1365-2133.2008.08520.x. Epub 2008 Mar 20.

PMID:
18363746
Items per page

Supplemental Content

Write to the Help Desk